Creative Biolabs-Immuno-oncology

Anti-DLG1 (clone 5LE2E) SynExpress pB-Cy3-I4-E Modified CD8+ T cells (CAT#: ITS-1224-CR2082)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLG1 (clone 5LE2E). We employs the AAV (pBAD-Cy3-IL-4-EcoRI) vector components and the SynExpress system of the Coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DLG1
Clone
5LE2E
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
pBAD
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
AAV
Transformation Accuracy
0.93
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving